We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 982

Information gathering by in-house lawyer in order to obtain external advice may not be protected by legal advice privilege
  • Herbert Smith Freehills LLP
  • United Kingdom
  • November 7 2018

In a recent decision, the High Court has held that an in-house lawyer’s communications with an employee of the business, who was accepted to be her

Disclosure by mistake: Glaxo Wellcome v Sandoz
  • Clyde & Co LLP
  • United Kingdom
  • November 5 2018

Judge considers issues relating to legal advice privilege and disclosure of a document by mistake Two issues arose to be decided in this case: (1)

Public Procurement Case Law Update: Sanofi v HSE
  • Matheson
  • Ireland
  • October 24 2018

Life Sciences businesses eagerly awaited the High Court judgment of 12 October on Sanofi v HSE. It is the first final Irish court judgment on a

Request to re-open Glaxo ‘dual pricing’ case rejected by General Court: The end of the road for challenges to dual pricing?
  • Bristows
  • European Union
  • October 4 2018

Entering into agreements that erect barriers to parallel exports between EU markets is generally a high-risk endeavour, which is likely to attract the

Two Scientists Plead Guilty for Conspiring to Sell and Use GlaxoSmithKline’s Trade Secrets in China
  • Winston & Strawn LLP
  • USA
  • September 27 2018

At the end of August 2018, GlaxoSmithKline (GSK) research scientist, Dr. Yu Xue, pled guilty to conspiring to steal GSK’s trade secrets. Dr. Xue took

The Next Battle in Trade (Secrets) War with China
  • Crowell & Moring LLP
  • USA, China
  • September 20 2018

On September 14, 2018, a former scientist at GlaxoSmithKline (“GSK”) pled guilty to conspiring to steal trade secrets from his former employer. Dr

Mistake in pharmaceutical patent wording a hard pill to swallow
  • The Commercial Bar Association of Victoria
  • Australia
  • September 4 2018

Pain is, well, a pain. One medication commonly used to relieve and manage pain and fever is paracetamol. Paracetamol is safe in low doses, but at high

Paxil Verdict Overturned on Appeal - Preemption Evidence Couldn’t Be Clearer
  • Dechert LLP
  • USA
  • August 28 2018

We haven’t talked about the district court decisions in Dolin v. GlaxoSmithKline LLC, because in our opinion there simply hasn’t been anything good to

Seventh Circuit Finds Preemption in Reversing Generic Paxil Verdict Against GSK, But Passes on Deciding Innovator Liability Issues
  • Drinker Biddle & Reath LLP
  • USA
  • August 23 2018

In a much-anticipated ruling on the appeal of a $3 million verdict against GlaxoSmithKline (GSK) in a wrongful death case involving the Paxil generic

Potential EU-UK competition law divergence post-Brexit highlighted by conflicting approaches of UK Competition Appeal Tribunal in recent pharma cases
  • Mayer Brown
  • United Kingdom, European Union
  • August 14 2018

The UK Competition Appeal Tribunal (the "CAT") has recently issued two judgments relating to anticompetitive practices in the pharmaceutical sector